Ibandronate Sodium Injection
Product Images NDC 60505-6097

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 60505-6097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ibandronate 01)

A bar chart comparing lumbar spine bone mineral density (BMD) percentage increase between two doses of ibandronate sodium: 2.5 mg once daily orally and 3 mg every 3 months intravenously. The chart shows the 3 mg intravenous dose has a higher BMD increase, marked with a statistical significance indicator (p<0.001).*

FDA Label Image

Figures 2 (Ibandronate 02)

An instructional illustration showing three steps: Fig. 1 depicts a hand removing a cap or cover from a vial or container; Fig. 2 shows a hand inserting a syringe needle into the vial; Fig. 3 displays a close-up of the syringe with the plunger being pulled back, presumably to withdraw the medication. The images relate to preparation and administration of an intravenous injection.*

FDA Label Image

Ibandronate-04 (Ibandronate 04)

Label for Ibandronate Sodium Injection 3 mg/3 mL (1 mg/mL) intravenous injection, manufactured by Apotex Corp. The label shows dosage information, storage instructions, manufacturer details, and a barcode. It is designed for a 3 mL syringe and includes directions for single-use only.*

FDA Label Image

Ibandronate-05 (Ibandronate 05)

Ibandronate Sodium Injection 3 mg/3 mL (1 mg/mL) prefilled syringe label from Apotex Corp. The label specifies intravenous use only, single-use, sterile product, and detailed ingredient quantities per syringe. It includes storage instructions and manufacturer information (Gland Pharma Limited, India, and Apotex Corp., Florida). Lot and expiration date areas are marked for printing.*

FDA Label Image

Chemical Structure (Structure)

Chemical structure of ibandronate sodium, showing its molecular composition including phosphorus, oxygen, sodium, nitrogen, and carbon atoms, along with a water molecule (H2O) associated as a hydrate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.